CD34 and acute myeloid leukemia: Expanded pDCs in pDC-AML have been shown to share the same mutational landscape as CD34+ blasts and arise in association with RUNX1 mutations, which are the most common somatic alterations in pDC-AML, found in over 70% of patients [3,10].